Christoph Harms
- Molecular Biology top 5%
- Cellular and Molecular Neuroscience top 5%
- Neurology top 2%
- Oncology top 10%
- Epidemiology top 10%
- Co-authors
- Matthias EndresUlrich DirnaglKaren GertzHeide HörtnaglJuri KatchanovGolo KronenbergKlaus FinkAndreas Meisel
- Topics
- Neuroinflammation and Neurodegeneration Mechanisms (13 papers)Neuroscience and Neuropharmacology Research (11 papers)Ubiquitin and proteasome pathways (8 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Christoph Harms
79 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 129
- Molecular Biology 1.6k
- Cellular and Molecular Neuroscience 516
- Neurology 505
- Oncology 415
- Epidemiology 297
Countries citing papers authored by Christoph Harms
This map shows the geographic impact of Christoph Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Harms more than expected).
Fields of papers citing papers by Christoph Harms
This network shows the impact of papers produced by Christoph Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Harms. The network helps show where Christoph Harms may publish in the future.
Co-authorship network of co-authors of Christoph Harms
This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Harms. A scholar is included among the top collaborators of Christoph Harms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Harms. Christoph Harms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 21 | |
| 9 | 2 | |
| 10 | 15 | |
| 11 | 14 | |
| 12 | 8 | |
| 13 | 25 | |
| 14 | 8 | |
| 15 | 9 | |
| 16 | 53 | |
| 17 | 85 | |
| 18 | 25 | |
| 19 | 9 | |
| 20 | 50 |
About Christoph Harms
Christoph Harms is a scholar working on Neurology, Cellular and Molecular Neuroscience and Genetics, having authored 80 papers that have together received 3.3k indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (13 papers), Neuroscience and Neuropharmacology Research (11 papers) and Ubiquitin and proteasome pathways (8 papers). The work is most often cited by research in Neurology (505 citations), Developmental Neuroscience (249 citations) and Cellular and Molecular Neuroscience (516 citations). Christoph Harms has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Matthias Endres, Ulrich Dirnagl, Karen Gertz, Heide Hörtnagl, Juri Katchanov, Golo Kronenberg, Klaus Fink, Andreas Meisel, Ulrike Harms and Ludger Hauck. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.